ABEO

Abeona Therapeutics Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 9/10
  • Momentum↓ 4/10
Abeona Therapeutics sales and earnings growth
ABEO Growth
Great
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 170.98%
  • FCF Y/Y↓ -62.98%
Abeona Therapeutics gross and profit margin trends
ABEO Profitability
Great
  • Gross margin ↓ -22.00%
  • EPS margin↑ 20587.50%
  • ROIC↑ 86.10%
Abeona Therapeutics net debt vs free cash flow
ABEO Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 22.0

Abeona Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗